MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Industry news

Related news

Latest News

FDA Orders 2 Companies to Stop Marketing Unapproved Nitroglycerin Tablets
Icagen Reports Positive Results for ICA-105665 in Patients With Photosensitive Epilepsy
Oculus Innovative Sciences Receives First FDA Clearance for Microcyn
FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers
Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists
NeuroSearch announces new findings from the MermaiHD Phase III study supporting potential disease modifying properties of Huntexil
ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
Cannasat Therapeutics Reports Results for the Year Ended December 31, 2009
Opexa Therapeutics Reports Year End 2009 Financial Results
IntelGenx and Cannasat Announce Letter of Intent for Relivar License
More news... | RSS Feed...

Most Viewed

Data from a post hoc analysis using desmoteplase in ischaemic stroke presented at the International Stroke Conference

Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists

Novartis oral multiple sclerosis development compound Gilenia

Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy

CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial

IntelGenx and Cannasat Announce Letter of Intent for Relivar License

Diffusion Pharmaceuticals LLC Announces Publication of Three Studies Testing Trans Sodium Crocetinate (TSC); Statistically significant results seen in animal models of primary brain cancer, cerebral...

Copaxone

NeuroSearch announces new findings from the MermaiHD Phase III study supporting potential disease modifying properties of Huntexil

US FDA Approves New Indication for Crestor (Rosuvastatin Calcium)

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us